A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS)

Clinical trial NCT03387046 · TERMINATED

Trial details

NCT number: NCT03387046
Sponsor: Merck KGaA, Darmstadt, Germany
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2018-03-26
Primary completion: 2019-01-11
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.